Hepatitis C in children: A quaternary referral center perspective

Journal of Pediatric Gastroenterology and Nutrition

Volumn 43, Issue 2, 2006, Pages 209-216

  Rumbo, Carolina ^a   Fawaz, Rima L ^b   Emre, Sukru H ^a   Suchy, Frederick J ^a   Kerkar, Nanda ^a   Morotti, Raffaella A ^a   Shneider, Benjamin L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cirrhosis Interferon; Pegylated; Ribavirin; Transplant Liver

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; AZATHIOPRINE; IMMUNOGLOBULIN; INTERFERON; INTERLEUKIN 11; PEGINTERFERON; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RIBAVIRIN;

ADOLESCENT; ADULT; CHILD; CHILDHOOD DISEASE; DISEASE COURSE; FEMALE; FOLLOW UP; GENOTYPE; HEALTH CENTER; HEALTH PROGRAM; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFANT; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PATIENT ASSESSMENT; PATIENT REFERRAL; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; REVIEW; TREATMENT INDICATION; TREATMENT RESPONSE;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

HEPATITIS C VIRUS;

EID: 33746833726     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000228117.52229.32     Document Type: Review

References (44)

1. Alter MD, Kruszon-Moran OV, Nainan GM, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
2. Rumbo C. Hepatitis C: current approaches in pediatrics. Pediatr Transplant 2005;9:662-5.
3. Casiraghi MA, De Paschale M, Romano L, et al. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 2004;39:90-6.
4. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implement of blood-donor screening. N Engl J Med 1999;341:866-70.
5. Minola E, Prati D, Suter F, et al. Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood 2002;99:4588-91.
6. Badizadegan K, Jonas MM, Ott MJ, et al. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998;28:1416-23.
7. Bortolotti F, Guido M, Zancan L, et al. Long-term outcome of hepatitis C in children. Hepatology 2004;39:1455. [author reply, 1455-6].
8. Birnbaum A, Moy L, Shneider B. Hepatitis C in children [letter]. N Engl J Med 2000;342:290-1.
9. The French METAVIR Cooperative Study group. Intraobserver and interobserver variations in liver biopsy interpretation in patient with chronic hepatitis C. Hepatology 1994;20:15-20.
10. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-93.
11. Suriawinata A, Rosencrantz R, Shneider B, et al. A 12-year-old boy with chronic hepatitis C and post transplant hepatitis. Semin Liver Dis 2001;21:573-8.
12. Jonas M. Children with hepatitis C. Hepatology 2002;36:S173-8.
13. Jara P, Resti M, Hierro L, et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 2003;36:275-80.
14. Guido M, Bortolotti F, Leandro G, et al. Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? Am J Gastroenterol 2003;98:660-3.
15. The Organ Procurement and Transplantation Network-OPTN. Available at: http://www.optn.org/latestData/advancedData.asp. Accessed October 10, 2005.
16. Wirth S, Lang T, Gehring S, et al. Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Hepatology 2002;36:1280-4.
17. Puetz J, Thrower M, Kane R, et al. Combination therapy with ribavirin and interferon in a cohort of children with hepatitis C and haemophilia followed at a pediatric haemophilia treatment center. Haemophilia 2004;10:87-93.
18. Lackner H, Moser A, Deutsch J, et al. Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy. Pediatrics 2000;106:E53.
19. Gonzalez-Peralta R, Kelly D, Haber B, et al. Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety and pharmacokinetics. Hepatology 2005;42:1010-8.
20. Jacobson K, Murray K, Zellos A, et al. An analysis of published studies of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2002;34:52-8.
21. Wirth S, Pieper-Boustani H, Lang T, et al. Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology 2005;41:1013-8.
22. Lo Nigro L, La Spina M, Mirabile E, et al. Use of PEG-interferon alfa-2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL. Pediatr Blood Cancer 2004;43:185.
23. Schwarz KB, Mohan P, Narkewicz M, et al. The safety, efficacy and pharmacokinetics of peginterferon alfa-2a (40kb) in children with chronic hepatitis C. Gastroenterology 2003;124:A700.
24. Delgado-Borrego A, Jonas M. Treatment options for hepatitis C infection in children. Curr Treat Options Gastroenterol 2004;7:373-9.
25. Nickel T, Sonntag A, Backmund M, et al. Depression during therapy with interferon alpha-how long should an antidepressant treatment last? Pharmacopsychiatry 2005;38:102-4.
26. Fukunishi K, Tanaka H, Maruyama J, et al. Burns in a suicide attempt related to psychiatric side effects of interferon. Burns 1998;24:581-3.
27. Sonnenblick M, Rosin A. Cardiotoxicity of interferon. A review of 44 cases. Chest 1991;99:557-61.
28. Cormier M. The role of hepatitis C support groups. Gastroenterol Nurs 2005;28(3 suppl):S4-9.
29. Zickmund S, Ho EY, Masuda M, et al. "They treated me like a leper". Stigmatization and the quality of life of patients with hepatitis C. J Gen Intern Med 2003;18:835-44.
30. Fishman JA, Rubin RH, Koziel MJ, et al. Hepatitis C virus and organ transplantation. Transplantation 1996;62:147-54.
31. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002;36:3-10.
32. Gentil MA, Rocha JL, Rodriguez-Algarra G, et al. Impaired kidney transplant survival in patients with antibodies to hepatitis C virus. Nephrol Dial Transplant 1999;14:2455-60.
33. Gentil MA, Rocha JL, Pereira P, et al. High incidence of diabetes mellitus after kidney transplant in patients with hepatitis C. Nephron 1999;82:5.
34. Rivera M, Gentil MA, Sayago M, et al. Treatment of hepatitis C virus with interferon in hemodialysis patients awaiting kidney transplant. Transplant Proc 2005;37:1424-5.
35. Fabrizi F, Bunnapradist S, Martin P. Treatment of hepatitis C in potential kidney and heart transplant patients. Clin Liver Dis 2005;9:487-503. [viii].
36. Everson GT, Trotter J, Forman L, et al. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 2005;42:255-62.
37. Everson GT. Long-term outcome of patient with chronic hepatitis C and decompensated liver disease treated with LADR protocol [low-accelerating-dose- regimen]. Hepatology 2002;36:297A.
38. Forns X, Garcia-Retortillo M, Serrano T, et al. Antiviral therapy in patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation. J Hepatol 2003:389-96.
39. Alri L, Duffaut M, Selves J, et al. Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial. J Hepatol 2001;35:272-8.
40. Zimmerman S, Adkins D, Graham M, et al. Irreversible, severe congestive cardiomyopathy occurring in association with interferon alpha therapy. Cancer Biother 1994;9:291-9.
41. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002;8S:14-8.
42. Berenguer M, Prieto M, Palau A, et al. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis. Liver Transpl 2003;9:228-35.
43. Berenguer M. What determines the natural history of recurrent hepatitis C after liver transplantation? J Hepatol 2005;42:448-56.
44. Dove L. Management of hepatitis C after transplantation: a long way from success. Eur J Gastroenterol Hepatol 2004;16:1131-3.